Ophthalmology & Retina Billing Integrity Diagnostic

Eliminate multi-thousand dollar clawbacks on Anti-VEGF intravitreal injections (CPT 67028 with J0178/J2778), audit premium IOL cash bundles, and recover diagnostic imaging denials.

Ophthalmology and vitreoretinal surgery clinics carry extreme financial risk due to the immense cost of biologic injectable drugs (Eylea, Lucentis, Vabysmo). A single denied claim for an intravitreal injection (CPT 67028 + J0178) represents an unrecovered cash loss of $1,850 to $2,400. Payers exploit subtle prior authorization errors, laterality modifier omissions (-RT/-LT), and strict step-therapy rules to trigger denials. Our forensic ophthalmology audit ensures airtight drug inventory reconciliation, unilateral modifier accuracy, and cataract global surgical compliance.

Audit red flags

Anti-VEGF drug HCPCS units submitted incorrectly (e.g. billing 1 unit instead of the specific mg equivalent).
Laterality modifiers (-RT, -LT, -50) omitted on bilateral diagnostic scans (CPT 92134 OCT or 92250 fundus photos).
Commercial carriers retroactively clawing back injection fees claiming failure to trial off-label bevacizumab first.
Failure to obtain separate Advance Beneficiary Notices (ABN) for non-covered refractive premium IOL services.

Audit action plan

1. High-Cost Biologic Drug Inventory Reconciliation — Match physical vial serial numbers and invoice acquisition costs directly to ERA 835 reimbursements to eliminate drug leakage.
2. Medical Necessity Step-Therapy Audit — Audit clinical notes to verify failure of preferred tier-1 Anti-VEGF agents before escalating to tier-2 biologics.
3. Bilateral Surgery & Diagnostic Laterality Scrub — Implement automated scrubbing rules enforcing specific laterality modifiers on all ocular procedures.

Codes reviewed

67028 — Intravitreal Injection of Pharmacologic Agent
J0178 / J2778 — Aflibercept (Eylea) / Ranibizumab (Lucentis) per mg
66984 / 66982 — Cataract Surgery with IOL (Standard / Complex)
92134 — Optical Coherence Tomography (OCT) Retina Scan

Frequently asked questions

Can an ophthalmologist bill an OCT scan (CPT 92134) on the same day as an eye injection?

Yes. The OCT scan is medically necessary to assess macular thickness and evaluate response to therapy. Modifier 59 or -XU must be appended to the imaging code to satisfy payer claim editing systems.

How do you handle payer step-therapy denials for Eylea?

We file expedited ERISA appeals documenting clinical contraindications or documented failure of compounded bevacizumab (Avastin), backed by peer-reviewed American Academy of Ophthalmology (AAO) clinical trials.